Susanna Rachel Seay
Psychiatric/Mental Health · Austin, TXNPI 1134605785
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 256 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 20 manufacturers, the largest accounting for just 22.6% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,515, more than ten times the $129 reported in 2021. Among psychiatric/mental health clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 256 payments — averaging $18.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Tris Pharma Inc$548
- Otsuka America Pharmaceutical, Inc.$422
- Lundbeck LLC$391
- Corium, LLC$374
- Alkermes, Inc.$357
- plus $2K from 14 others
What the payments were for
- Food & beverage$4,742100%
- Education$10%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 72 | $1,072 |
| Tris Pharma Inc | 31 | $548 |
| Otsuka America Pharmaceutical, Inc. | 22 | $422 |
| Lundbeck LLC | 19 | $391 |
| Corium, LLC | 15 | $374 |
| Alkermes, Inc. | 18 | $357 |
| Takeda Pharmaceuticals U.S.A., Inc. | 18 | $353 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 18 | $304 |
| Bausch Health US, LLC | 9 | $186 |
| Axsome Therapeutics, Inc. | 7 | $181 |
| Vanda Pharmaceuticals Inc. | 6 | $136 |
| Johnson & Johnson | 4 | $93 |
| Noven Therapeutics, LLC | 4 | $77 |
| Supernus Pharmaceuticals, Inc. | 4 | $62 |
| Idorsia Pharmaceuticals US Inc | 3 | $56 |
| Ironshore Pharmaceuticals Inc. | 2 | $37 |
| Teva Pharmaceuticals USA, Inc. | 1 | $36 |
| Neurocrine Biosciences, Inc. | 1 | $23 |
| Alfasigma USA, Inc. | 1 | $19 |
| Lilly USA, LLC | 1 | $17 |
How this compares
$4,743 in reported general payments places this provider in the 90th percentile of 2,724 psychiatric/mental health providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lurasidone Hcl | 12 | $8,634 |
| Alprazolam | 14 | $384 |
| Lamotrigine | 28 | $297 |
| Bupropion XlBupropion Hcl | 13 | $216 |
| Sertraline Hcl | 21 | $215 |
| Escitalopram Oxalate | 11 | $192 |
| Fluoxetine Hcl | 16 | $171 |
| Zolpidem Tartrate ErZolpidem Tartrate | 11 | $122 |
| Buspirone Hcl | 11 | $116 |
| Gabapentin | 12 | $76 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Austin
- Jaime Nelson DensonAustin$88K
- Camille WatsonAustin$34K
- Suzanne GranthamAustin$31K
- Lin CaiAustin$16K
- Tracy HicksLongview$684K
- Natalie TellezHouston$602K
- Karah BrashierRichardson$567K
- Grant DavisRichardson$360K
- Victor IlogEl Paso$167K
- Lisa ShamblinGrapevine$163K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.